Accelerating the Pipeline of COVID-19 Antiviral Drugs: Insights from Leading Experts

There are a large range of scientific approaches to developing COVID-19 antiviral drugs, and a lot of promising possibilities.  But investors want to know which drugs can get to market fastest and have the most public health impact.  This Boundless webinar will be moderated by Gillian Sandler from Galapont, and feature Dr. William A. Hastline, Chair and President of ACCESS Health International, Dr. Deepak Srivastava of Gladstone Institutes, and Ly Nguyen-Jatkoe, Global Director of Content of Informa Pharma Intelligence. Don’t miss this fascinating discussion on how impact investors can accelerate the pipeline of COVID-19 antiviral drugs.